Stephan C - Search Results

1

Reduced serum selenoprotein P concentrations in German prostate cancer patients.

Meyer HA, Hollenbach B, Stephan C, Endermann T, Morgenthaler NG, Cammann H, Köhrle J, Jung K, Schomburg L. Meyer HA, et al. Among authors: stephan c. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2386-90. doi: 10.1158/1055-9965.EPI-09-0262. Epub 2009 Aug 18. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19690186

2

Analytical performance and clinical validity of two free prostate-specific antigen assays compared.

Jung K, Stephan C, Lein M, Henke W, Schnorr D, Brux B, Schürenkämper P, Loening SA. Jung K, et al. Among authors: stephan c. Clin Chem. 1996 Jul;42(7):1026-33. Clin Chem. 1996. PMID: 8674185

3

The ratio of free to total prostate-specific antigen in serum is correlated to the prostate volume.

Stephan C, Jung K, Lein M, Schnorr D, Loening SA. Stephan C, et al. Int J Cancer. 1996 Jul 29;67(3):461-2. doi: 10.1002/(SICI)1097-0215(19960729)67:3<461::AID-IJC25>3.0.CO;2-9. Int J Cancer. 1996. PMID: 8707426 No abstract available.

4

The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia.

Stephan C, Lein M, Jung K, Schnorr D, Loening SA. Stephan C, et al. Cancer. 1997 Jan 1;79(1):104-9. Cancer. 1997. PMID: 8988733

5

Re: Editorial: can prostate specific antigen derivatives reduce the frequency of unnecessary prostate biopsies?

Stephan C, Lein M, Jung K, Schnorr D, Loening SA. Stephan C, et al. J Urol. 1997 Apr;157(4):1371. doi: 10.1016/s0022-5347(01)64987-5. J Urol. 1997. PMID: 9120953 No abstract available.

6

Elimination of serum free and total prostate-specific antigen after radical retropubic prostatectomy.

Lein M, Brux B, Jung K, Henke W, Koenig F, Stephan C, Schnorr D, Loening SA. Lein M, et al. Among authors: stephan c. Eur J Clin Chem Clin Biochem. 1997 Aug;35(8):591-5. doi: 10.1515/cclm.1997.35.8.591. Eur J Clin Chem Clin Biochem. 1997. PMID: 9298348

7

Relation of free PSA/total PSA in serum for differentiating between patients with prostatic cancer and benign hyperplasia of the prostate: which cutoff should be used?

Lein M, Stephan C, Jung K, Schnorr D, Loening S. Lein M, et al. Among authors: stephan c. Cancer Invest. 1998;16(1):45-9. doi: 10.3109/07357909809039753. Cancer Invest. 1998. PMID: 9474251 Review.

8

Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma.

Lein M, Jung K, Laube C, Hübner T, Winkelmann B, Stephan C, Hauptmann S, Rudolph B, Schnorr D, Loening SA. Lein M, et al. Among authors: stephan c. Int J Cancer. 2000 Mar 15;85(6):801-4. doi: 10.1002/(sici)1097-0215(20000315)85:6<801::aid-ijc11>3.0.co;2-c. Int J Cancer. 2000. PMID: 10709099

9

ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: proof of new complex forming of PSA after release into circulation.

Stephan C, Jung K, Brux B, Lein M, Sinha P, Schnorr D, Loening SA. Stephan C, et al. Urology. 2000 Apr;55(4):560-3. doi: 10.1016/s0090-4295(99)00548-8. Urology. 2000. PMID: 10736503

10

Elimination of serum complexed prostate-specific antigen after radical retropubic prostatectomy.

Stephan C, Jung K, Brux B, Lein M, Sinha P, Schnorr D, Loening SA. Stephan C, et al. Clin Chem Lab Med. 2000 Apr;38(4):309-11. doi: 10.1515/CCLM.2000.044. Clin Chem Lab Med. 2000. PMID: 10928650

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

956 results

Search Page

Filters